Scientists in Israel are conducting open clinical trials utilizing whole plant cannabis in search of an autism spectrum disorder treatment after stumbling upon a tremendous observation in an unrelated study.
Bonni Goldstein M.D., resident Marijuana.com medical expert and published author, said the early evidence shows autism is a result of genetic mutations and a deficit in the endocannabinoid system. Goldstein noted, “one case report and numerous anecdotal reports [have revealed] that cannabinoids may help some children with this disorder have better communication, less repetitive behaviors, less anxiety, and better social interaction.”
A study published in 2013 compared the number of cannabinoid receptors on blood cells in autistic children to aged-match healthy children. Researchers discovered a stark difference between children with autism and those without.
The study showed that children with autism had more cannabinoid receptors on their white blood cells — the body was essentially increasing its intake valve as a way to consume more cannabinoids. This suggests a possible cannabinoid deficiency in children with autism spectrum disorder, researchers believe…